Key terms
About OM
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest OM news
Yesterday
3:59am ET
RBC Capital Sticks to Its Hold Rating for Outset Medical (OM)
Apr 08
6:55am ET
Outset Medical: Overcoming Challenges with Strong Market Potential and Recurring Revenue Growth
Apr 08
6:44am ET
Outset Medical initiated with a Buy at BTIG
Apr 05
7:25am ET
Outset Medical upgraded to Buy from Neutral at CL King
Mar 13
4:32pm ET
Outset Medical Board Changes: New Director Appointed, Szyman Steps Down
Mar 05
9:44am ET
Novo FLOW trial results positive for Outset Medical, says RBC Capital
Feb 22
8:10am ET
Analysts Offer Insights on Healthcare Companies: Outset Medical (OM), Exact Sciences (EXAS) and DarioHealth (DRIO)
Feb 22
7:40am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Crispr Therapeutics AG (CRSP), Alcon (ALC) and Outset Medical (OM)
Feb 22
12:00am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Feb 21
4:35pm ET
Outset Medical affirms FY24 revenue view of $145M-$153M, consensus $148.8M
Feb 21
4:34pm ET
Outset Medical reports Q4 EPS (59c), consensus (61c)
Feb 21
4:24pm ET
Outset Medical CCO Steve Williamson to Depart for CEO Role
No recent press releases are available for OM
OM Financials
Key terms
Ad Feedback
OM Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
OM Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range